Back to companies

KPC Pharmaceuticals Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

KPC Pharmaceuticals Inc (KPC Pharmaceuticals) is a producer of natural botanical drugs. The company carries out drug research and development, production, sales, commercial wholesale, and international marketing. It offers luotai injection, luotai soft capsule, xuesaitong injection, gastrodine tablets, acetagastrodin tablets, gastrodin injection, gastrodin capsules, helicid drugs, compound artemisia spray, qiyeshen’an tablets, artemisinin and naphthoquine phosphate tablets, comether tablets, artemether injection and artemesinin-based combination therapy (act) antimalarial drugs among others. KPC Pharmaceuticals markets its products under the brands Luotai, Tianxuanqing, Artemedine, Artem and Arco. The company's products are used for the treatment of central nervous system disorders, cardiovascular, cardio-cerebral-vascular, chronic disease, disorders, and malaria. It has operations across Europe, Africa, Oceania, and South America. KPC is headquartered in Kunming, Yunnan, China.

Gain a 360-degree view of KPC Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of KPC Pharmaceuticals Inc and make more informed decisions for your business Register your interest
Headquarters China

Address No. 166, Keyi Road, Kunming National High-tech Industrial Development Zone, Yunnan, 650106


Telephone 86 871 68324311

No of Employees 5,072

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 600422 (SHA)

Revenue (2024) $914.9M -21.7% (2024 vs 2023)

EPS XYZ

Net Income (2024) XYZ -46% (2024 vs 2023)

Market Cap* $981.1M

Net Profit Margin (2024) XYZ -31.0% (2024 vs 2023)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

KPC Pharmaceuticals Inc premium industry data and analytics

20+

Clinical Trials

Determine KPC Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Marketed Drugs

Understand KPC Pharmaceuticals Inc’s commercialized product portfolio to stay one step ahead of the market.

12+

Catalyst Calendar

Proactively evaluate KPC Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

3

Pipeline Drugs

Identify which of KPC Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products Brands
Panax Notoginseng: Luotai
Luotai Injection Tianxuanqing
Luotai Soft Capsule Artemedine
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand KPC Pharmaceuticals Inc portfolio and identify potential areas for collaboration Understand KPC Pharmaceuticals Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters KPC Pharmaceuticals Inc Shenzhen Neptunus Bioengineering Co Ltd Tasly Pharmaceutical Group Co Ltd Jiangsu Nhwa Pharmaceutical Co Ltd Guizhou YiBai Pharmaceutical Co Ltd
Headquarters China China China China China
City Kunming Shenzhen Tianjin Xuzhou Guiyang
State/Province Yunnan Guangdong Tianjin Jiangsu Guizhou
No. of Employees 5,072 6,734 10,563 6,003 4,832
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Yu Xiang Chairman Executive Board - -
Yan Wei Vice Chairman Executive Board - -
Deng Kang Vice Chairman Executive Board - -
Zhong Jiang President; Director Executive Board - -
Sun Zhiqiang Chief Financial Officer; Secretary Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into KPC Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into KPC Pharmaceuticals Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?